Pelvic floor disorders in women with premature ovarian insufficiency: a cross-sectional study.
Journal
Menopause (New York, N.Y.)
ISSN: 1530-0374
Titre abrégé: Menopause
Pays: United States
ID NLM: 9433353
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
14
3
2020
medline:
1
1
2021
entrez:
14
3
2020
Statut:
ppublish
Résumé
This study aimed to investigate the prevalence of self-reported main pelvic floor disorders (PFD) (urinary incontinence [UI], pelvic organ prolapse [POP], and fecal incontinence [FI]) and its associated factors in women with premature ovarian insufficiency (POI) and a control group. This was a cross-sectional study wherein two groups were interviewed from August, 2017 to November, 2018-women with POI (n = 150) and a control group matched for age and body weight (n = 150). Sociodemographic variables and two questionnaires validated in Brazilian Portuguese language for PFD (Kings Health Questionnaire [KHQ] and Pelvic Floor Distress Inventory-20 [PFDI-20]) were used. Laycock's power, endurance, repetitions, fast contractions, every contraction timed (PERFECT) scale for pelvic floor muscle assessment was used in both groups. The prevalence of self-reported UI was 27.33% and 37.33% for POI and control groups (P > 0.05), respectively. There was no perceived difference regarding the prevalence of POP (9.33% POI group vs 8% control group; P = 0.682) and FI (8% POI vs 4% control group; P = 0.145). The P (power) (P = 0.46), E (endurance) (P = 0.91), R (repetitions) (P = 0.88), and F (fast contractions) (P = 0.19) values were statistically similar in both the groups. Multivariate analysis (n = 141) showed that higher weight (odds ratio [OR] 1.047 [1.018-1.076]; P < 0.001) and gravidity rates (OR 1.627 [1.169-2.266]; P < 0.01) were risk factors for UI and higher weight (OR 1.046 [1.010-1.084]; P = 0.01), and presence of comorbidities (OR 8.75 [1.07-71.44]; P < 0.01) were risk factors for POP in the POI group; there was no variable that was associated with FI. Women with POI did not have significant differences when compared with the control group regarding the prevalence of PFD and pelvic floor muscle assessment. Having higher weight and gravidity rates were associated with self-reported UI, while the presence of comorbidities and higher weight were risk factors for POP in the POI group. : Video Summary:http://links.lww.com/MENO/A555.
Identifiants
pubmed: 32168199
doi: 10.1097/GME.0000000000001523
pii: 00042192-202004000-00013
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
450-458Références
Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31:926–937.
Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016; 215:704–711.
Calik-Ksepka A, Grymowicz M, Rudnicka E, et al. Signs and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiency. Prz Menopauzalny 2018; 17:131–134.
Smith P, Heimer G, Norgren A, Ulmsten U. Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Invest 1990; 30:27–30.
Smith P. Estrogens and urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Acta Obstet Gynecol Scand Suppl 1993; 157:1–26.
Soderberg MW, Johansson B, Masironi B, et al. Pelvic floor sex steroid hormone receptors, distribution and expression in pre- and posmenopausal stress urinary incontinent women. Acta Obstet Gynecol Scand 2007; 86:1377–1384.
Dumoulin C, Pazzoto Cacciari L, Mercier J. Keeping the pelvic floor healthy. Climacteric 2019; 22:257–262.
Souza CE, Bezerra LM, Pereira RW, Moura TK, Oliveira RJ. Comparative study of pelvic floor function in continent and incontinent postmenopausal women. Braz J Physical Therapy 2009; 13:535–541.
Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Bai SW. Risk factors for pelvic organ prolapse. Int J Gynaecol Obstet 2007; 98:248–251.
Staller K, Townsend MK, Khalili H, et al. Menopausal hormone therapy is associated with increased risk of fecal incontinence in women after menopause. Gastroenterology 2017; 152:1915–1921.
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; 21:5–26.
Associacion Medica Mundial. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones medicas en seres humanos; 2013. Available at: https://www.wma.net. Accessed September 12, 2019.
Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 2011; 113:3–13.
Arouca MA, Duarte TB, Lott DA, et al. Validation and cultural translation for Brazilian Portuguese version of the Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20). Int Urogynecol J 2016; 27:1097–1106.
Tamanini JT, D’Ancona CA, Botega NJ, Rodrigues Netto N Jr. [Validation of the Portuguese version of the King's Health Questionnaire for urinary incontinent women]. Rev Saude Publica 2003; 37:203–211.
SAS Institute. The SAS system for Windows. Release 9.2. Cary, NC; SAS Institute; 2011.
Erekson EA, Li FY, Martin DK, Fried TR. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause 2016; 23:368–375.
Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J 2017; 28:1165–1170.
Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet 2007; 369:1027–1038.
Miner PB Jr. Economic and personal impact of fecal and urinary incontinence. Gastroenterology 2004; 126: (1 Suppl 1): S8–S13.
Tan R, Pu D, Cao J, et al. Prevalence of stress urinary incontinence in women with premature ovarian insufficiency. J Womens Health (Larchmt) 2018; doi: 10.1089/jwh.2018.6935 [Epub ahead of print].
doi: 10.1089/jwh.2018.6935
Parden AM, Griffin RL, Hoover K, et al. Prevalence, awareness, and understanding of pelvic floor disorders in adolescent and young women. Female Pelvic Med Reconstr Surg 2016; 22:346–354.
Borello-France DF, Handa VL, Brown MB, et al. Pelvic-floor muscle function in women with pelvic organ prolapse. Phys Ther 2007; 87:399–407.
Frota IPR, Rocha ABO, Neto JAV, et al. Pelvic floor muscle function and quality of life in postmenopausal women with and without pelvic floor dysfunction. Acta Obstet Gynecol Scand 2018; 97:552–559.
Volloyhaug I, Morkved S, Salvesen O, Salvesen KA. Assessment of pelvic floor muscle contraction with palpation, perineometry and transperineal ultrasound: a cross-sectional study. Ultrasound Obstet Gynecol 2016; 47:768–773.
Albrich S, Steetskamp J, Knoechel SL, Porta S, Hoffmann G, Skala C. Assessment of pelvic floor muscle contractility: digital palpation versus 2D and 3D perineal ultrasound. Arch Gynecol Obstet 2016; 293:839–843.
Sartori MG, Feldner PC, Jarmy-Di Bella ZI, et al. Sexual steroids in urogynecology. Climacteric 2011; 14:5–14.
Al-Badr A, Ross S, Soroka D, Drutz HP. What is the available evidence for hormone replacement therapy in women with stress urinary incontinence? J Obstet Gynaecol Can 2003; 25:567–574.
Pollanen E, Kangas R, Horttanainen M, et al. Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status. Aging Cell 2015; 14:236–248.
Hagglund D, Olsson H, Leppert J. Urinary incontinence: an unexpected large problem among young females. Results from a population-based study. Fam Pract 1999; 16:506–509.
Greer WJ, Richter HE, Bartolucci AA, Burgio KL. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol 2008; 112 (2 Pt 1):341–349.
Kudish BI, Iglesia CB, Sokol RJ, et al. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol 2009; 113:81–88.
Isik H, Aynioglu O, Sahbaz A, Selimoglu R, Timur H, Harma M. Are hypertension and diabetes mellitus risk factors for pelvic organ prolapse? Eur J Obstet Gynecol Reprod Biol 2016; 197:59–62.